The end of an era of cancer drug discovery: life without new drug targets
Immuno-Oncology Insights 2022; 3(4), 189–194
10.18609/ioi.2022.021
Published: 12 April 2022
Viewpoint
Armen Mardiros & Alexander Kamb A2 Biotherapeutics, Inc.
“We believe that cell therapy is the therapeutic modality best suited to overcome the present challenges in oncology.”